Project: PRJEB18261
RNA sequencing of A431 cell line samples before and after gefitinib treatment, at 0, 2, 6 and 24 hours, was performed in order to characterize the cell line's early and late response to this drug, and to compare against proteomics (mass spectrometry) characterization of the cell line using the same setup. These data were used in Branca et al., HiRIEF LC-MS enables deep proteome coverage and unbiased proteogenomics., Nat Methods. 2014 Jan;11(1):59-62 (doi: 10.1038/nmeth.2732).
Secondary Study Accession:
ERP020187
Study Title:
RNA-seq of A431 cell line after gefitinib treatment
Center Name:
European Bioinformatics Institute;Science for Life Laboratory;Department of Biochemistry and Biophysics;Stockholm University
Study Name:
RNA-seq of A431 cell line after gefitinib treatment
Broker Name:
ArrayExpress
ENA-FIRST-PUBLIC:
2016-12-01
ENA-LAST-UPDATE:
2016-11-30